Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-97-003475
Filing Date
1997-03-31
Accepted
1997-03-31 00:00:00
Documents
9
Period of Report
1996-12-31
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 THERAPEUTIC ANTIBODIES, INC. FORM 10-K 10-K 200830
2 OFFICE LEASE AGREEMENT EX-10.8 58044
3 SUBLEASE EX-10.9 14972
4 ASSIGNMENT EX-10.10 37699
5 CLINICAL TRIALS AND REGISTRATION AGREEMENT EX-10.19 51871
6 SERVICE AGREEMENT EX-10.20 26881
7 SERVICE AGREEMENT EX-10.21 27071
8 COMPUTATION OF PER SHARE EARNINGS EX-11.1 4874
9 FINANCIAL DATA SCHEDULE EX-27 2000
  Complete submission text file 0000950144-97-003475.txt   426536
Mailing Address 1500 21ST AVE SOUTH STE 310 NASHVILLE TN 37212
Business Address 1500 21ST AVE SOUTH STE 310 NASHVILLE TN 37212 6153271027
THERAPEUTIC ANTIBODIES INC /DE (Filer) CIK: 0000944744 (see all company filings)

EIN.: 621212485 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-25978 | Film No.: 97569785
SIC: 8071 Services-Medical Laboratories